B

Bonus Biogroup Ltd
TASE:BONS

Watchlist Manager
Bonus Biogroup Ltd
TASE:BONS
Watchlist
Price: 9.8 ILS 5.38% Market Closed
Market Cap: 119.9m ILS
Have any thoughts about
Bonus Biogroup Ltd?
Write Note
BONS
/
Income Statement
/
Operating Income

Bonus Biogroup Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bonus Biogroup Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bonus Biogroup Ltd
TASE:BONS
Operating Income
-₪29.8m
CAGR 3-Years
19%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Operating Income
-$6.6m
CAGR 3-Years
-6%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Operating Income
$17.7m
CAGR 3-Years
62%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Operating Income
-$18.7m
CAGR 3-Years
-12%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Operating Income
-$83.7m
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Operating Income
-$7.1m
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Bonus Biogroup Ltd
Glance View

Market Cap
119.9m ILS
Industry
Biotechnology

Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

BONS Intrinsic Value
0.41 ILS
Overvaluation 96%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is Bonus Biogroup Ltd's Operating Income?
Operating Income
-29.8m ILS

Based on the financial report for Jun 30, 2024, Bonus Biogroup Ltd's Operating Income amounts to -29.8m ILS.

What is Bonus Biogroup Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-10%

Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Bonus Biogroup Ltd have been 19% over the past three years , -7% over the past five years , and -10% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.